Pemetrexed Disodium and Carboplatin or Cisplatin With or Without Erlotinib Hydrochloride in Treating Patient With Stage IV Non-Small Cell Lung Cancer Resistant to First-Line Therapy With Erlotinib Hydrochloride or Gefitinib

NCT01928160 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped study not accruing

Conditions

Recurrent Non-small Cell Lung Cancer
Stage IV Non-small Cell Lung Cancer

Interventions

DRUG: pemetrexed disodium
DRUG: carboplatin
DRUG: cisplatin
DRUG: erlotinib hydrochloride
OTHER: laboratory biomarker analysis

Sponsor

Vanderbilt-Ingram Cancer Center

Collaborators

[object Object]